Zhi Qu

1.5k citations
28 papers · 1.2k indexed · h-index 17
Topics
Nanoparticle-Based Drug Delivery (10 papers)Advanced Drug Delivery Systems (8 papers)RNA Interference and Gene Delivery (6 papers)
Partner nations
AustraliaChinaGermany

In The Last Decade

Zhi Qu

26 papers receiving 1.2k citations

Peers

Zhi Qu
Comparison fields: 5 of 108
  • Biomaterials 392
  • Molecular Biology 367
  • Materials Chemistry 262
  • Pharmaceutical Science 240
  • Biomedical Engineering 216
Replace Siddharth Jambhrunkar with:
Siddharth Jambhrunkar Australia
Rudra Pangeni South Korea
Neelam Poonia India
Tiehong Yang China
Hibah M. Aldawsari Saudi Arabia
Naisarg Pujara Australia
Krassimira Yoncheva Bulgaria
Yunlong Ge China
Prakash Ramalingam South Korea
Zhi Qu relative to Siddharth Jambhrunkar Australia Siddharth Jambhrunkar's profile →
Citations per field
00.5×1.5×
Siddharth Jambhrunkar · 1×
Citations per year

Countries citing papers authored by Zhi Qu

Since Specialization
Citations

This map shows the geographic impact of Zhi Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Qu more than expected).

Fields of papers citing papers by Zhi Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhi Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Qu. The network helps show where Zhi Qu may publish in the future.

Co-authorship network of co-authors of Zhi Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhi Qu. A scholar is included among the top collaborators of Zhi Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhi Qu. Zhi Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 9
5 10
6 9
7 31
8 102
9 38
10 43
11 53
12 102
13 1
14 2
15 115
16 106
17 31
18 247
19 66
20 92

About Zhi Qu

Zhi Qu is a scholar working on Pharmaceutical Science, Geriatrics and Gerontology and Biomaterials, having authored 28 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Advanced Drug Delivery Systems (8 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Geriatrics and Gerontology (180 citations), Pharmaceutical Science (240 citations) and Biomaterials (392 citations). Zhi Qu has collaborated with scholars based in Australia, China and Germany. Frequent co-authors include Amirali Popat, Siddharth Jambhrunkar, Sachin Thakur, Tushar Kumeria, Michael A. McGuckin, Prarthana Rewatkar, Naisarg Pujara, Muhammad Mustafa Abeer, Surajit Karmakar and Chengzhong Yu. Their work appears in journals such as Scientific Reports, Journal of Colloid and Interface Science and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026